Anti-Inflammatory Properties of Azelnidipine, a Dihydropyridine-Based Calcium Channel Blocker

REFERENCES

• Schiffrin EL. Vascular and cardiac benefits of angiotensin receptor blockers. Am J Med 2002;113:409–418.
   PubMed Web of Science ®Google Scholar
• Schmieder RE. Mechanisms for the clinical benefits of angiotensin II receptor blockers. Am J Hypertens 2005;18:720–730.
   PubMed Web of Science ®Google Scholar
• Stojiljkovic L, Behnia R. Role of renin angiotensin system inhibitors in cardiovascular and renal protection: A lesson from clinical trials. Curr Pharm Des 2007;13:1335–1345.
   PubMed Web of Science ®Google Scholar
• Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol EJ. CAMELOT Investigators. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: A randomized controlled trial. JAMA 2004;292:2217–2225.
   PubMed Web of Science ®Google Scholar
• Naruse M, Tanabe A, Seki T, Adachi C, Yoshimoto T, Mishina N, Imaki T, Naruse K, Demura R, Demura H. Effects of two calcium channel blockers on messenger RNA expression of endothelin-1 and nitric oxide synthase in cardiovascular tissue of hypertensive rats. J Hypertens 1999;17:53–60.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999;340:115–126.
   PubMed Web of Science ®Google Scholar
• Hanson GK, Libby P, Schönbeck U, Yan ZO. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002;1:281–291.
   Google Scholar
• Libby P, Aikawa M. Stabilization of atherosclerosis plaques: New mechanism and clinical targets. Nat Med 2002;8:1257–1262.
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Inagaki Y, Nakamura K, Imaizumi T. Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties. J Cardiovasc Pharmacol 2004;43:724–730.
   PubMed Web of Science ®Google Scholar
• Matsui T, Yamagishi S, Nakamura K, Kikuchi S, Inoue H. Azelnidipine, a dihydropyridine-based calcium antagonist, inhibits angiotensin II-induced oxidative stress generation and downregulation of pigment epithelium-derived factor mRNA levels in microvascular endothelial cells. Drugs Exp Clin Res 2005;31:215–219.
   PubMedGoogle Scholar
• Nakano K, Egashira K, Ohtani K, Gang Z, Iwata E, Miyagawa M, Sunagawa K. Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and mice. Atherosclerosis 2008;196:172–179.
   PubMed Web of Science ®Google Scholar
• Nakano K, Egashira K, Tada H, Kohjimoto Y, Hirouchi Y, Kitajima S, Endo Y, Li XH, Sunagawa K. A third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in non-human primates. J Hypertens 2006;24:1881–1889.
   PubMed Web of Science ®Google Scholar
• Carson RT, Vignali DA. Simultaneous quantification of 15 cytokines using a multiplex flow cytometric assay. J Immunol Methods 1999;227:41–52.
   PubMed Web of Science ®Google Scholar
• Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A, and mannose binding protein in human serum. Ann Clin Biochem 1998;35:745–753.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T. Quantitative immunohistochemical determination of 8-hydroxy-2-deoxyguanosine by a monoclonal antibody N45.1: Its application to ferric nitrotriacetate-induced renal carcinogenesis model. Lab Invest 1997;76:365–374.
   PubMed Web of Science ®Google Scholar
• Matsui T, Yamagishi S, Nakamura K, Inoue H. Azelnidipine, a new long-acting calcium-channel blocker, inhibits tumour necrosis factor-alpha-induced monocyte chemoattractant protein-1 expression in endothelial cells. J Int Med Res 2006;34:671–675.
   PubMed Web of Science ®Google Scholar
• Schroder JM, Christophers E. Secretion of novel and homologous neutrophil-activating peptides by lipopolysaccharide (LPS)-stimulated human endothelial cells. J Immunol 1989;142:244–251.
   PubMed Web of Science ®Google Scholar
• Wang JM, Sica A, Peri G, Walter S, Padura IM, Libby P, Ceska M, Lindley I, Colotta F, Mantovani A. Expression of monocyte chemotactic protein and IL-8 by cytokine-activated human vascular smooth muscle cells. Arterioscl Thromb 1991;11:1166–1174.
   PubMed Web of Science ®Google Scholar
• Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988;167:1547–1559.
   PubMed Web of Science ®Google Scholar
• Kuhns D, Young HA, Gallin EK, Gallin JI. Ca2+ dependent production and release of IL-8 in human neutrophils. J Immunol 1998;161:4332–4339.
   PubMed Web of Science ®Google Scholar
• Yue TL, Wang X, Sung CP, Olson B, McKenna PJ, Gu JL, Feuerstein GZ. Interleukin-8, a mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 1994;75:1–7.
   PubMed Web of Science ®Google Scholar
• Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MAJr, Luster AD, Luscinskas FW, Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow condition. Nature 1999;398:718–723.
   PubMed Web of Science ®Google Scholar
• Molad Y, Haines KA, Anderson DC, Buyon JP, Cronstein BN. Immunocomplexes stimulate different signaling events to chemoattractants in the neutrophil and regulate L-selectin and β2-integrin expression differently. Biochem J 1994;299:881–887.
   PubMed Web of Science ®Google Scholar
• Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, Renlund DG, Muhlestein JB; Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45:1638–1643.
   PubMed Web of Science ®Google Scholar
• Inoue T, Komoda H, Nonaka M, Kameda M, Uchida T, Node K. Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol 2008;124:319–325.
   PubMed Web of Science ®Google Scholar
• Pan ZK, Chen LY, Cochrane CG, Zuraw BL. fMet-Leu-Phe stimulates proinflammatory cytokine gene expression in human peripheral blood monocytes: The role of phosphatidylinositol 3-kinase. J Immunol 2000;164:404–411.
   PubMed Web of Science ®Google Scholar
• Wilson L, Butcher CJ, Kellie S. Calcium ionophore A23187 induces interleukin-8 gene expression and protein secretion in human monocytic cells. FEBS Lett 1993;325:295–297.
   PubMed Web of Science ®Google Scholar
• Willmott NJ, Choudhury Q, Flower RJ. Functional importance of the dihydropyridine-sensitive, yet voltage-insensitive store-operated Ca2+ influx of U937 cells. FEBS Lett 1996;39:159–164.
   Google Scholar
• Lee C, Xu D, Feketeova E, Kannan KB, Fecker Z, Deitch EA, Livingston DH, Hauser CJ. Store-operated calcium channel inhibition attenuates neutrophil function and postshock acute lung injury. J Trauma 2005;59:56–63.
   PubMed Web of Science ®Google Scholar